Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in …
NL Albert, M Weller, B Suchorska, N Galldiks… - Neuro …, 2016 - academic.oup.com
This guideline provides recommendations for the use of PET imaging in gliomas. The review
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …
Advances in neuro-oncology imaging
KJ Langen, N Galldiks, E Hattingen… - Nature Reviews …, 2017 - nature.com
Despite the fact that MRI has evolved to become the standard method for diagnosis and
monitoring of patients with brain tumours, conventional MRI sequences have two key …
monitoring of patients with brain tumours, conventional MRI sequences have two key …
PET imaging in patients with brain metastasis—report of the RANO/PET group
Brain metastases (BM) from extracranial cancer are associated with significant morbidity and
mortality. Effective local treatment options are stereotactic radiotherapy, including …
mortality. Effective local treatment options are stereotactic radiotherapy, including …
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-l-tyrosine PET
N Galldiks, V Dunkl, G Stoffels, M Hutterer… - European journal of …, 2015 - Springer
Purpose The follow-up of glioblastoma patients after radiochemotherapy with conventional
MRI can be difficult since reactive alterations to the blood–brain barrier with contrast …
MRI can be difficult since reactive alterations to the blood–brain barrier with contrast …
IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein–specific PET/CT
M Röhrich, A Loktev, AK Wefers, A Altmann… - European journal of …, 2019 - Springer
Purpose Targeting fibroblast activation protein (FAP) is a new diagnostic approach allowing
the visualization of tumor stroma. Here, we applied FAP-specific PET imaging to gliomas …
the visualization of tumor stroma. Here, we applied FAP-specific PET imaging to gliomas …
Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis
V Dunet, A Pomoni, A Hottinger… - Neuro …, 2015 - academic.oup.com
Background For the past decade 18F-fluoro-ethyl-l-tyrosine (FET) and 18F-fluoro-deoxy-
glucose (FDG) positron emission tomography (PET) have been used for the assessment of …
glucose (FDG) positron emission tomography (PET) have been used for the assessment of …
Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy
G Ceccon, P Lohmann, G Stoffels, N Judov… - Neuro …, 2017 - academic.oup.com
Background The aim of this study was to investigate the potential of dynamic O-(2-[18F]
fluoroethyl)-L-tyrosine (18F-FET) PET for differentiating local recurrent brain metastasis from …
fluoroethyl)-L-tyrosine (18F-FET) PET for differentiating local recurrent brain metastasis from …
Prognostic significance of dynamic 18F-FET PET in newly diagnosed astrocytic high-grade glioma
NL Jansen, B Suchorska, V Wenter… - Journal of Nuclear …, 2015 - Soc Nuclear Med
Despite advances in diagnosis and the use of different therapeutic regimens in astrocytic
high-grade glioma (HGG), the prognosis for patients remains grim. Additional pretherapeutic …
high-grade glioma (HGG), the prognosis for patients remains grim. Additional pretherapeutic …
From the clinician's point of view-What is the status quo of positron emission tomography in patients with brain tumors?
The most common type of primary brain tumor is malignant glioma. Despite intensive
therapeutic efforts, the majority of these neoplasms remain incurable. Imaging techniques …
therapeutic efforts, the majority of these neoplasms remain incurable. Imaging techniques …
Opportunities for improving brain cancer treatment outcomes through imaging-based mathematical modeling of the delivery of radiotherapy and immunotherapy
Immunotherapy has become a fourth pillar in the treatment of brain tumors and, when
combined with radiation therapy, may improve patient outcomes and reduce the …
combined with radiation therapy, may improve patient outcomes and reduce the …